⌘K
EN
FR
Acquisition du traitement Yescarta (Axicabtagène ciloleucel) pour lymphome | Government contract · CanPursue
Contracts
active
Acquisition du traitement Yescarta (Axicabtagène ciloleucel) pour lymphome
Santé Québec Est-de-l’Île-de-Montréal – Universitaire
GILEAD SCIENCES CANADA, INC.
EA-0659-2024-02
Watch
Total contract value
$9.7M
Original award value
$9.7M
Start
Nov 14, 2024
End
—
Timeline
Official
Awarded
Nov 14, 2024. Original award value: $9.7M